Annotation Detail

Information
Associated Genes
RET
Associated Variants
RET p.Cys634Trp (p.C634W) ( ENST00000713926.1, ENST00000340058.6, ENST00000615310.5, ENST00000355710.8 )
RET p.Cys634Trp (p.C634W) ( ENST00000340058.6, ENST00000355710.8, ENST00000615310.5, ENST00000713926.1 )
Associated Disease
thyroid gland medullary carcinoma
Source Database
CIViC Evidence
Description
Medullary thyroid cancer cells with RET C634W mutation are insensitive to motesanib, compared to wild-type RET.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/75
Gene URL
https://civic.genome.wustl.edu/links/genes/42
Variant URL
https://civic.genome.wustl.edu/links/variants/112
Rating
3
Evidence Type
Predictive
Disease
Thyroid Gland Medullary Carcinoma
Evidence Direction
Supports
Drug
Motesanib
Evidence Level
D
Clinical Significance
Resistance
Pubmed
21422803
Drugs
Drug NameSensitivitySupported
MotesanibResitance or Non-Reponsetrue